Archive • Date 2026-05-09 • Filed 2026-05-09T14:17:05Z • Case SH-20260509-001 • Severity 3/5
Vague Allegations Without Substantiation; Anonymous Sourcing Substituted for Specificity
Based on: White House prepares to replace FDA leader Marty Makary amid agency turmoil • Washington Post Politics • 2026-05-08T23:19:14Z
Charge: The article alleges months of FDA turmoil and criticism of Makary's decisions without naming a single decision or describing a single incident. Evidence: The entire factual foundation rests on two anonymous sources describing internal operations, with zero specifics about what turmoil occurred or which decisions drew fire. Missing: Specific examples of FDA turmoil or dysfunction; Names and descriptions of at least one decision Makary made that drew criticism. Hypocrisy: It demands trust while withholding basics like Specific examples of FDA turmoil or dysfunction and Names and descriptions of at least one decision Makary made that drew criticism (not provided in the snippet). Verdict: Allegation without evidence is gossip wearing a byline. Note: The Post managed to report that something happened without explaining what, which is a remarkable achievement in the field of journalism (or its current substitute).
Findings
- The article claims months of turmoil at the FDA but provides zero examples, incidents, or dates.
- Criticism of Makary's decisions is asserted but not a single decision is named or described.
- The entire story rests on two anonymous sources; no named officials, no direct quotes, no verifiable attribution.
- The phrase agency turmoil functions as an incantation rather than a description.
- Readers learn a personnel decision was made but not why, when, or based on what actual conduct.
- Missing: Specific examples of FDA turmoil or dysfunction
- Missing: Names and descriptions of at least one decision Makary made that drew criticism
- Missing: Identity or position of either anonymous source
- Missing: Timeline for replacement or effective date
- Missing: Any statement from Makary, White House officials on the record, or FDA staff responding to allegations
Records requested
- Specific examples of FDA turmoil or dysfunction
- Names and descriptions of at least one decision Makary made that drew criticism
- Identity or position of either anonymous source
- Timeline for replacement or effective date
- Any statement from Makary, White House officials on the record, or FDA staff responding to allegations
Hypocrisy: It demands trust while withholding basics like Specific examples of FDA turmoil or dysfunction and Names and descriptions of at least one decision Makary made that drew criticism (not provided in the snippet).
Recommended sentence
Retract the story pending named sources and specific examples, or reframe as opinion. Anonymous allegations of turmoil without incident description do not meet reporting standards.